These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27130143)

  • 1. Recombinant human erythropoietin improves neurological outcomes in very preterm infants.
    Song J; Sun H; Xu F; Kang W; Gao L; Guo J; Zhang Y; Xia L; Wang X; Zhu C
    Ann Neurol; 2016 Jul; 80(1):24-34. PubMed ID: 27130143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage.
    Song J; Wang Y; Xu F; Sun H; Zhang X; Xia L; Zhang S; Li K; Peng X; Li B; Zhang Y; Kang W; Wang X; Zhu C
    CNS Drugs; 2021 Jun; 35(6):681-690. PubMed ID: 33959935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants.
    Sun H; Song J; Kang W; Wang Y; Sun X; Zhou C; Xiong H; Xu F; Li M; Zhang X; Yu Z; Peng X; Li B; Xu Y; Xing S; Wang X; Zhu C
    J Transl Med; 2020 Oct; 18(1):397. PubMed ID: 33076939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial.
    Wang Y; Song J; Sun H; Xu F; Li K; Nie C; Zhang X; Peng X; Xia L; Shen Z; Yuan X; Zhang S; Ding X; Zhang Y; Kang W; Qian L; Zhou W; Wang X; Cheng X; Zhu C
    J Transl Med; 2020 Aug; 18(1):308. PubMed ID: 32771013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the protective effect of recombinant human erythropoietin (rhEPO) for neurodevelopment in preterm infants.
    Wang H; Zhang L; Jin Y
    Cell Biochem Biophys; 2015 Mar; 71(2):795-802. PubMed ID: 25300689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained low-dose prophylactic early erythropoietin for improvement of neurological outcomes in preterm infants:A systematic review and meta-analysis.
    Liang L; Yu J; Xiao L; Wang G
    J Affect Disord; 2021 Mar; 282():1187-1192. PubMed ID: 33601694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants: A meta-analysis.
    Qin N; Qin H
    Medicine (Baltimore); 2021 May; 100(18):e25805. PubMed ID: 33950982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.
    Leuchter RH; Gui L; Poncet A; Hagmann C; Lodygensky GA; Martin E; Koller B; Darqué A; Bucher HU; Hüppi PS
    JAMA; 2014 Aug; 312(8):817-24. PubMed ID: 25157725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Early Erythropoietin for Neuroprotection in Preterm Infants: A Meta-analysis.
    Fischer HS; Reibel NJ; Bührer C; Dame C
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early treatment of premature infants with recombinant human erythropoietin.
    Messer J; Haddad J; Donato L; Astruc D; Matis J
    Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial.
    Picotti E; Reinelt T; Koller B; Bucher HU; Rüegger CM; Fauchère JC; Natalucci G;
    JAMA Netw Open; 2022 Dec; 5(12):e2245499. PubMed ID: 36477478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage: The EpoRepair Randomized Clinical Trial.
    Wellmann S; Hagmann CF; von Felten S; Held L; Klebermass-Schrehof K; Truttmann AC; Knöpfli C; Fauchère JC; Bührer C; Bucher HU; Rüegger CM;
    JAMA Netw Open; 2022 Dec; 5(12):e2244744. PubMed ID: 36459138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteral granulocyte-colony stimulating factor and erythropoietin early in life improves feeding tolerance in preterm infants: a randomized controlled trial.
    El-Ganzoury MM; Awad HA; El-Farrash RA; El-Gammasy TM; Ismail EA; Mohamed HE; Suliman SM
    J Pediatr; 2014 Dec; 165(6):1140-1145.e1. PubMed ID: 25155966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.
    Fauchère JC; Koller BM; Tschopp A; Dame C; Ruegger C; Bucher HU;
    J Pediatr; 2015 Jul; 167(1):52-7.e1-3. PubMed ID: 25863661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.
    Ohls RK; Ehrenkranz RA; Das A; Dusick AM; Yolton K; Romano E; Delaney-Black V; Papile LA; Simon NP; Steichen JJ; Lee KG;
    Pediatrics; 2004 Nov; 114(5):1287-91. PubMed ID: 15520109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of early application of recombinant human erythropoietin on white matter development in preterm infants].
    Yang SS; Xu FL; Cheng HQ; Xu HR; Yang L; Xing JY; Cheng L
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):346-351. PubMed ID: 29764568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.